Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma
Ke Liu(Air Force Medical University), Ying Zhou(Xijing Hospital), Jiaxin Zhong(Xiamen University), Yuanyuan Zeng(Sichuan University), Jintao Guo(Xiamen University), Qiyuan Li(Dana-Farber Cancer Institute), Chaoqun Xu(Ocean University of China), Peiyang Fan(Xiamen University), Kuai Liu(Xiamen University)
Cited by 25
Related Papers
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
|Journal of Clinical Oncology|2010|983
Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
|Cancer Discovery|2012|684
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
|Molecular Cancer|2018|369
Paradoxical Relationship between Chromosomal Instability and Survival Outcome in Cancer
|Cancer Research|2011|363